Association between interleukin-22 genetic polymorphisms and bladder cancer risk

Area of Science:

• Oncology
• Immunology
• Genetics

Background:

• Interleukin-22 (IL-22) is a cytokine implicated in cancer development and progression.
• The specific role of IL-22 in bladder cancer pathogenesis remained uninvestigated prior to this study.

Purpose of the Study:

• To investigate the association between IL-22 gene polymorphisms and bladder cancer risk.
• To explore the potential role of IL-22 in bladder cancer development.

Main Methods:

• A case-control study involving 210 bladder cancer patients and 210 healthy controls.
• Genotyping of three common IL-22 gene polymorphisms (-429 C/T, +1046 T/A, +1995 A/C) using fluorogenic 5' exonuclease assays.

Main Results:

• A significantly higher frequency of the IL-22 -429 TT genotype and T allele was observed in bladder cancer patients compared to controls.
• The IL-22 -429 TT genotype was associated with a lower risk in superficial bladder cancer.
• No significant association was found for IL-22 +1046 T/A and +1995 A/C polymorphisms with bladder cancer risk.

Conclusions:

• This study is the first to report an association between the IL-22 -429 C/T gene polymorphism and bladder cancer risk.
• Further research is warranted to validate these findings and elucidate the underlying mechanisms.